100+ Brands Featured
Average Organic Traffic Growth
Biggest % Grower
Biggest % Loss
Our reports have been the UK’s No.1 search marketing benchmark for the last 10 years! Marketing decision makers spanning 60 sectors have downloaded our reports to save over 72 hours of research and discover exactly how their brand ranks against the competition in search, visibility, and growth potential.
I was extremely impressed with the insight and depth of analysis in the Salience Report... The data-driven analysis tracking visibility, authority, links, page speed, search volume, keywords, and more paints a detailed picture of brand performance and emerging trends. The team was delighted to be featured.
The UK's No.1 Online Pharmacy Industry Report
Between March 2025 and March 2026, the UK online pharmacy market grew +15.00% in aggregate organic search traffic across 344 tracked brands. That’s the headline. It’s also the easiest number to misread, because the +15% was distributed almost entirely toward brands most consumers have never heard of.
Boots grew +13.94%. The largest pharmacy brand in the UK, with 5,000,000 monthly brand searches, moved -1.06% versus market. Lloyds fell -4.71%, –19.71% versus a market that gained 15. The Independent Pharmacy fell -37.84% from rank 5 to rank 8. Meanwhile Chemist4U grew +210.03%, Weldricks grew +126.86%, and Oxford Online Pharmacy grew +55.05%. None of those three are top-of-mind pharmacy names. All three beat the market by 40 percentage points or more.
Pharmacy is YMYL, Your Money or Your Life, Google’s most scrutinised trust framework. For consumer-facing pharmacy domains, trustworthiness at scale is proxied by Trustpilot review volume, recency, and clinical signal density. Which means the brands taking growth in 2026 aren’t winning on awareness. They’re winning on the algorithmic trust signal that awareness doesn’t supply.
| Brand | YoY Growth | Vs +15% Market |
|---|---|---|
| Ashcroft Pharmacy | -84.33% | -99.33% |
| The Independent Pharmacy | -37.84% | -52.84% |
| Lloyds Pharmacy | -4.71% | -19.71% |
| Boots | +13.94% | -1.06% |
| Market benchmark | +15.00% | – |
| ASDA Online Doctor | +12.79% | -2.21% |
| Pharmacy2U | +32.95% | +17.95% |
| Oxford Online Pharmacy | +55.05% | +40.05% |
| Weldricks | +126.86% | +111.86% |
| Chemist4U | +210.03% | +195.03% |
Boots holds rank 1 with 13,494,517 monthly visits. ASDA Online Doctor sits at rank 2 with 1,449,332. Lloyds Pharmacy holds rank 3 with 760,921. The headline ranks look stable, three of the top five are recognisable household names. Apply the vs-market column and the rankings reorganise themselves around a different mechanism.
Chemist4U at rank 5 grew +195.03 percentage points above market. Weldricks at rank 11 grew +111.86 above market. Oxford Online Pharmacy at rank 9 grew +40.05 above market. None of these brands have the brand-search infrastructure of the top three. All three are taking organic growth from brands that do.
| Brand | Organic Rank | Mar 2026 Visits | YoY Growth | Vs +15% Market |
|---|---|---|---|---|
| Boots | 1 | 13,494,517 | +13.94% | -1.06% |
| ASDA Online Doctor | 2 | 1,449,332 | +12.79% | -2.21% |
| Lloyds Pharmacy | 3 | 760,921 | -4.71% | -19.71% |
| MedExpress | 4 | 503,930 | +7.06% | -7.94% |
| Chemist4U | 5 ↑3 | 503,626 | +210.03% | +195.03% |
Three of the top four are growing below market. The brand at rank 5 grew almost fourteen times the market rate. Without the vs-market lens, that signal is invisible. With it, the picture is unambiguous: rank position is preserved by inertia and brand-search volume; growth is being earned somewhere else, by domains running a different operating model.
If there is one comparison in this index that should rewire the marketing-meeting conversation, it is this. Boots has 5,000,000 monthly brand searches, the largest brand-search footprint in UK pharmacy by a factor of 20. Lloyds Pharmacy has 246,000. Combined, they represent a brand-equity asset that no challenger in this dataset can replicate inside a decade. Both domains grew below the +15.00% market rate.
Boots grew +13.94%, which is +1,650,491 visits in absolute terms, the biggest absolute gain in the dataset. It is also the data point most likely to mislead a quarterly review. At scale, “near market” is structural decline. Share loss at -1.06% per year compounds. Over five years, that gap becomes a different competitive position.
lloydspharmacy.com fell -4.71%; combined with onlinedoctor.lloydspharmacy.com, the Lloyds estate lost -45,402 visits net year-on-year, in a market that gained 15. With 246,000 monthly brand searches and BRS rank 5, Lloyds has the brand asset. The organic channel is not converting it.
| Brand | BRS Rank | Brand Searches/mo | YoY Organic Growth | Vs +15% Market |
|---|---|---|---|---|
| Boots | #1 | 5,000,000 | +13.94% | -1.06% |
| Lloyds Pharmacy | #5 | 246,000 | -4.71% | -19.71% |
| Chemist4U | #14 | 33,100 | +210.03% | +195.03% |
| Weldricks | #29 | 6,600 | +126.86% | +111.86% |
While Boots, Lloyds, and ASDA Online Doctor underperformed the +15% benchmark, a tier of mid-rank pharmacies all grew significantly above market. None of these are new entrants. They have been compounding review volume, condition-led content, and clinical trust signals while the category leaders relied on brand awareness to do work the algorithm doesn’t reward.
| Brand | YoY Growth | Vs +15% Market | Rank Move |
|---|---|---|---|
| Market benchmark | +15.00% | – | – |
| Pharmacy2U | +32.95% | +17.95% | → |
| Oxford Online Pharmacy | +55.05% | +40.05% | ↑4 |
| Click2Pharmacy | +57.25% | +42.25% | ↑3 |
| e-Surgery | +59.14% | +44.14% | ↑3 |
| Weldricks | +126.86% | +111.86% | ↑7 |
| Chemist4U | +210.03% | +195.03% | ↑3 |
| Bolt Pharmacy | +800% | +785% | ↑39 |
Chemist4U added 341,184 visits in twelve months, the second-largest absolute traffic gain in the dataset. Bolt Pharmacy climbed 39 ranks at +800% YoY. Weldricks climbed seven ranks. None of these brands are running above-the-line campaigns capable of moving organic rank by themselves. They are running review-acquisition and condition-content programmes that the YMYL trust framework reads as algorithmic credibility, and that credibility compounds.
The mechanism is non-branded intent capture: being present when someone searches “buy 10mg diazepam” or “24 hour drug store” or “ozempic alternatives UK,” rather than waiting for them to type your brand name. The traffic these brands are accumulating is mostly net new, patients who never had a pharmacy preference, served by the domain Google decided to trust.
Still scrolling? Here's the full 69-page report.
Download the free reportDigital performance reports covering 60+ industries within retail, finance and B2B.
